Publicaciones en las que colabora con Rogelio González Sarmiento (31)

2024

  1. Biología celular y molecular del cáncer

    Oncología clínica (Arán Ediciones), pp. 13-23

2023

  1. Telomere Length as a New Risk Marker of Early-Onset Colorectal Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

2022

  1. Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy

    Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88

  2. Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis

    Biomedicines, Vol. 10, Núm. 2

2021

  1. Dopamine receptors and the kidney: An overview of health-and pharmacological-targeted implications

    Biomolecules, Vol. 11, Núm. 2, pp. 1-16

  2. Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors

    Life, Vol. 11, Núm. 12

  3. Resistance to immune checkpoint inhibitors secondary to myeloid-derived suppressor cells: A new therapeutic targeting of haematological malignancies

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  4. The influence of diet and probiotics on the response of solid tumours to immunotherapy: Present and future perspectives

    Applied Sciences (Switzerland), Vol. 11, Núm. 18

2020

  1. Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Genetic susceptibility in head and neck squamous cell carcinoma in a spanish population

    Cancers, Vol. 11, Núm. 4

2017

  1. Analysis of autophagy gene polymorphisms in Spanish patients with head and neck squamous cell carcinoma

    Scientific Reports, Vol. 7, Núm. 1

  2. Biología Celular y Molecular del Cáncer

    Oncología Clínica (Elsevier España), pp. 5-11

2016

  1. Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally advanced head and neck squamous cell carcinoma (HNSCC) in a Spanish population

    Oral Oncology, Vol. 63, pp. 38-43

2015

  1. Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach

    Genome Biology, Vol. 16, Núm. 1

2014

  1. Analysis of DNA repair gene polymorphisms in glioblastoma

    Gene, Vol. 536, Núm. 1, pp. 79-83

  2. Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers

    Breast Cancer Research and Treatment, Vol. 148, Núm. 2, pp. 415-421

  3. Role of XRCC3, XRCC1 and XPD single-nucleotide polymorphisms in survival outcomes following adjuvant chemotherapy in early stage breast cancer patients

    Clinical and Translational Oncology, Vol. 16, Núm. 2, pp. 158-165

2013

  1. Integrated Analysis of Mismatch Repair System in Malignant Astrocytomas

    PLoS ONE, Vol. 8, Núm. 9

2011

  1. Pacientes con criterios clínicos de síndrome de Lynch con y sin mutación en genes reparadores del ADN (MLH1 y MSH2). Un reto para el clínico

    Medicina Clinica, Vol. 137, Núm. 4, pp. 166-170

2008

  1. Medicina molecular: la medicina del siglo XXI

    Real Academia de Medicina de Salamanca